This is a biospecimen procurement protocol to characterize the immune response to zoonotic virus exposure in healthy adult humans aged 18 to 65 years with high-risk exposure to animals or their excreta (e.g., guano farming and wet markets), or living within 5 km of animal habitats (e.g., bat caves and bat roosts) in Cambodia.
This is a biospecimen procurement protocol to characterize immune signatures to zoonotic virus exposure in healthy adult humans aged 18 to 65 years who handle suspected infected animals or their excreta, or living within 5 km of animal reservoirs, in Cambodia. The primary study objective is to characterize immunity to zoonotic viruses, specifically H5N1. To meet this objective, when possible, individuals with the highest likelihood of prior exposure to the viruses of interest (Nipahvirus, bCoVs, H5N1) will be screened for study inclusion. These high-exposure risk behaviors include direct handling of known or suspected infected animals or their excreta. If insufficient individuals meeting these criteria are found, then sampling will include individuals with lower risk exposures, including living or working in areas proximal to (within 5 km of) animal habitats. All human subjects research activities will be conducted by study personnel within the International Center of Excellence in Research Cambodia, Cambodian CCDC, and the Forestry Administration of the Royal Government of Cambodia. NIH investigators are involved in study design, implementation, analysis of coded samples and data, and writing and dissemination of reports of study results. Although they may support Cambodian investigators in monitoring/oversight capacities, NIH investigators will not be engaged in human subjects research.
Study Type
OBSERVATIONAL
Enrollment
400
30 mL at Day 0 with optional visits for up to 2 additional whole blood collections at least 30 days apart
Communicable Disease Control Department
Battambang, Cambodia
RECRUITINGCommunicable Disease Control Department
Kampong Thom, Cambodia
RECRUITINGCommunicable Disease Control Department
Kampot, Cambodia
Antibody binding activity in plasma samples against known immunodominant zoonotic viral proteins
Measured by binding antibody titer greater than cutoffs established from healthy U.S. donors (3 standard deviations above mean signal intensity) to a panel of either henipaviruses, influenza viruses, or sarbecoviruses
Time frame: Day 0 and 2 optional visits at least 30 days apart between Day 180-720
Neutralizing activity of plasma samples against known immunodominant zoonotic viral proteins
Measured by circulating antigen-specific B cells constituting approximately 0.001%-0.005% total PBMCs
Time frame: Day 0 and 2 optional visits at least 30 days apart between Day 180-720
Isolate viral antigen-specific B cells for phenotyping and immunoglobulin sequencing
Measured by isolation of an expected 20 million PBMCs from whole blood samples, yielding approximately 100-500 antigen-specific B cells for single-cell B-cell sequencing (anticipated cell death up to 50% during the isolation and sorting process)
Time frame: Day 0 and 2 optional visits at least 30 days apart between Day 180-720
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Communicable Disease Control Department
Stung Treng, Cambodia
RECRUITINGCommunicable Disease Control Department
Takeo, Cambodia
RECRUITING